本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

11.52
+0.59005.40%
盤前11.45-0.0700-0.61%05:45 EDT
成交量:30.72萬
成交額:347.10萬
市值:5.63億
市盈率:-3.59
高:11.70
開:10.83
低:10.49
收:10.93
52周最高:14.53
52周最低:2.22
股本:4,888.58萬
流通股本:1,989.95萬
量比:1.01
換手率:1.54%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
淨資產收益率:-36.58%
總資產收益率:-22.34%
市淨率:1.62
市盈率(LYR):-3.36

資料載入中...

公司資料

公司名字:
Artiva Biotherapeutics, Inc.
交易所:
NASDAQ
成立時間:
2019
員工人數:
115
公司地址:
5505 Morehouse Drive,Suite 100,San Diego,California,United States
郵編:
92121
電話:
傳真:
- -
簡介:
Artiva Biotherapeutics, Inc.於2019年2月14日在特拉華州註冊成立。該公司是一家臨床階段的生物技術公司,專註於為患有破壞性自身免疫性疾病和癌症的患者開發基於自然殺傷(NK)細胞的療法。

董事

名稱
職位
Fred Aslan
Director,Chief Executive Officer,Principal Accounting Officer and Principal Financial Officer
Alison Moore
Independent Director
Brian Daniels
Chairperson of the Board and Independent Director
Daniel Baker
Independent Director
Elaine Sorg
Independent Director
Elizabeth Hougen
Independent Director
Laura Stoppel
Independent Director

股東

名稱
職位
Fred Aslan
Director,Chief Executive Officer,Principal Accounting Officer and Principal Financial Officer
Jennifer Bush
Chief Operating Officer, Chief Legal Officer and Compliance Officer
Christopher P. Horan
Chief Technical Operations Officer
Diego Miralles
President and Head of Research and Development
Subhashis Banerjee
Chief Medical Officer